Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
We provide a synopsis of the 2024 update of the 2018 National Guideline for the Clinical Management of Opioid Use Disorder, from the Canadian Research Initiative in Substance Matters (CRISM).
The scope of the Publicly Available Specification (PAS) focuses on health-care providers who are able to prescribe medications in Canada with specific emphasis on prescribers who do not consider th
A human rights approach is essential to eliminating hepatitis C virus (HCV) as a public health threat, and capturing the social, cultural, economic, and other barriers to the enjoyment of rights, i
To provide guidance on evidence-based strategies for the treatment of stimulant use disorders (StUDs), stimulant intoxication, and stimulant withdrawal, as well as se
This is a compilation of information and recommendations for the implementation and use of SROM in OAT.
The purpose of this guidance is to provide policy recommendations for territorial, provincial and federal takehome naloxone (THN) programs, using evidence from scientific and grey literature and co
Our objective was to provide preventive care recommendations that promote health equity by prioritizing effective interventions for people experiencing disadvantages.
We conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017.